| 666308 |
FRONTIERS IN GENETICS |
An Omnibus Test for Detecting Multiple Phenotype Associations Based on GWAS Summary Level Data |
2021-03-17 |
10.3389/fgene.2021.644419 |
Liu Wei, Guo Yunshan, Liu Zhonghua |
| 666307 |
FRONTIERS IN GENETICS |
Systematic Characterization of Expression Profiles and Prognostic Values of the Eight Subunits of the Chaperonin TRiC in Breast Cancer |
2021-03-17 |
10.3389/fgene.2021.637887 |
Xu Wen-Xiu, Song Wei, Jiang Meng-Ping, Yang Su-Jin, Zhang Jian, Wang Dan-Dan, Tang Jin-Hai |
| 666306 |
FRONTIERS IN ONCOLOGY |
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond |
2021-03-17 |
10.3389/fonc.2021.612354 |
Orth Michael, Albrecht Valerie, Seidl Karin, Kinzel Linda, Unger Kristian, Hess Julia, Kreutzer Lisa, Sun Na, Stegen Benjamin, Nieto Alexander, Maas Jessica, Winssinger Nicolas, Friedl Anna A., Walch Axel K., Belka Claus, Zitzelsberger Horst, Niyazi Maximilian, Lauber Kirsten |
| 666305 |
FRONTIERS IN ONCOLOGY |
Molecular Subtypes and CD4+ Memory T Cell-Based Signature Associated With Clinical Outcomes in Gastric Cancer |
2021-03-17 |
10.3389/fonc.2020.626912 |
Ning Zhi-Kun, Hu Ce-Gui, Huang Chao, Liu Jiang, Zhou Tai-Cheng, Zong Zhen |
| 666304 |
FRONTIERS IN ONCOLOGY |
Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway |
2021-03-17 |
10.3389/fonc.2021.642229 |
Wei Xuan, Shi Juanjuan, Lin Qianhan, Ma Xiaoxue, Pang Yingxin, Mao Hongluan, Li Rui, Lu Wei, Wang Yu, Liu Peishu |
| 666303 |
FRONTIERS IN ONCOLOGY |
Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer |
2021-03-17 |
10.3389/fonc.2021.632657 |
Yoon Sungpil, Wang Xiaoju, Vongpunswad Sompong, Tromp Gerard, Kuivaniemi Helena |
| 666302 |
FRONTIERS IN ONCOLOGY |
Case Report: Primary NK/T Cell Lymphoma Nasal Type of the Colon With Multiple Intestinal Perforations |
2021-03-17 |
10.3389/fonc.2021.577939 |
Zhang Yan, Liu Weiping, Zhang Xinyue, Wu Bing |
| 666301 |
FRONTIERS IN ONCOLOGY |
Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials |
2021-03-17 |
10.3389/fonc.2021.640690 |
Schreiber Anna R., Kagihara Jodi A., Weiss Jennifer A., Nicklawsky Andrew, Gao Dexiang, Borges Virginia F., Kabos Peter, Diamond Jennifer R. |
| 666300 |
FRONTIERS IN ONCOLOGY |
Importance of Microvascular Invasion Risk and Tumor Size on Recurrence and Survival of Hepatocellular Carcinoma After Anatomical Resection and Non-anatomical Resection |
2021-03-17 |
10.3389/fonc.2021.621622 |
Hu Haoyu, Qi Shuo, Zeng Silue, Zhang Peng, He Linyun, Wen Sai, Zeng Ning, Yang Jian, Zhang Weiqi, Zhu Wen, Xiang Nan, Fang Chihua |
| 666299 |
FRONTIERS IN ONCOLOGY |
Comprehensive Analysis of the Functions and Prognostic Value of RNA-Binding Proteins in Thyroid Cancer |
2021-03-17 |
10.3389/fonc.2021.625007 |
Ma Yue, Yin Shi, Liu Xiao-feng, Hu Jing, Cai Ning, Zhang Xiao-bei, Fu Li, Cao Xu-chen, Yu Yue |
